Saliva: an emerging biofluid for early detection of diseases.

The capability to assess physiological states, detect morbidity initiation and progression, and monitor posttreatment therapeutic outcomes through a noninvasive approach is one of the most desirable goals for healthcare research and delivery. Saliva, a multi-constituent oral fluid, has high potential for the surveillance of general health and disease. To reach the above goal through saliva-based diagnostics, two prerequisites must be fulfilled: (1) discovering biomarker(s) for different diseases among the complicated components of saliva, and (2) advancing sensitivity and specificity of biomarker(s) through persistent development of technologies. Under the support and research blueprint initiated by the National Institute of Dental and Craniofacial Research (NIDCR), salivary diagnostics has not only steadily progressed with respect to accuracy and availability, but has also bridged up-to-date nanotechnology to expand the areas of application. With collective efforts over several years, saliva has been demonstrated to be a promising bodily fluid for early detection of diseases, and salivary diagnostics has exhibited tremendous potential in clinical applications. This review presents an overview of the value of saliva as a credible diagnostic tool, the discovery of salivary biomarkers, and the development of salivary diagnostics now and in the future.

[1]  R. Haeckel,et al.  Application of saliva for drug monitoring. An in vivo model for transmembrane transport. , 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[2]  A. Tenório,et al.  Detection and typing of lymphotropic herpesviruses by multiplex polymerase chain reaction. , 1999, Journal of virological methods.

[3]  M. Popoli,et al.  Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases , 2001, Neuropharmacology.

[4]  Amy E Herr,et al.  Microfluidic immunoassays as rapid saliva-based clinical diagnostics , 2007, Proceedings of the National Academy of Sciences.

[5]  F Wold,et al.  Posttranslational covalent modification of proteins. , 1977, Science.

[6]  H. Craighead,et al.  Powering an inorganic nanodevice with a biomolecular motor. , 2000, Science.

[7]  D. Kidwell,et al.  Testing for drugs of abuse in saliva and sweat. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[8]  David Elashoff,et al.  Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.

[9]  I. Mandel,et al.  Salivary diagnosis: more than a lick and a promise. , 1993, Journal of the American Dental Association.

[10]  G. Duff,et al.  The interleukin-1 genotype as a severity factor in adult periodontal disease. , 1997, Journal of clinical periodontology.

[11]  Mc,et al.  Accuracy of oral specimen testing for human immunodeficiency virus. , 1997, The American journal of medicine.

[12]  Chih-Ming Ho,et al.  Single-molecule tracing on a fluidic microchip for quantitative detection of low-abundance nucleic acids. , 2005, Journal of the American Chemical Society.

[13]  K. Narayan,et al.  Prevention of type 2 diabetes , 2001, BMJ : British Medical Journal.

[14]  Zongyuan Chen,et al.  A disposable microfluidic cassette for DNA amplification and detection. , 2006, Lab on a chip.

[15]  Chih-Ming Ho,et al.  An electrochemical detection scheme for identification of single nucleotide polymorphisms using hairpin-forming probes. , 2002, Nucleic acids research.

[16]  N. Beeching,et al.  Salivary sampling for hepatitis B surface antigen carriage: a sensitive technique suitable for epidemiological studies. , 1995, Annals of Tropical Paediatrics.

[17]  R. Nagler,et al.  Concomitant Analysis of Salivary Tumor Markers—A New Diagnostic Tool for Oral Cancer , 2006, Clinical Cancer Research.

[18]  John T McDevitt,et al.  Toward the development of a lab-on-a-chip dual-function leukocyte and C-reactive protein analysis method for the assessment of inflammation and cardiac risk. , 2005, Clinical chemistry.

[19]  D. Malamud.  Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. , 1997, The American journal of medicine.

[20]  H. Slavkin,et al.  Toward molecularly based diagnostics for the oral cavity. , 1998, Journal of the American Dental Association.

[21]  G. Csako,et al.  Biochemical Composition and Electrolyte Balance of Unstimulated Whole Human Saliva , 2000 .

[22]  J. Grogan,et al.  Saliva and Dental Pellicle-A Review , 2000, Advances in dental research.

[23]  David Elashoff,et al.  Serum circulating human mRNA profiling and its utility for oral cancer detection. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  N. Park,et al.  Characterization of RNA in Saliva , 2006, Clinical chemistry.

[25]  Ruedi Aebersold,et al.  Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry , 2005, Nature Methods.

[26]  R. Haeckel,et al.  The application of saliva, sweat and tear fluid for diagnostic purposes. , 1993, Annales de biologie clinique.

[27]  Nils Brünner,et al.  Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers* , 2008, Molecular & Cellular Proteomics.

[28]  A. Vissink,et al.  Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.

[29]  D. Wong,et al.  RNA Profiling of Cell-free Saliva Using Microarray Technology , 2004, Journal of dental research.

[30]  H. Mulcahy,et al.  Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients , 2004, Cancer and Metastasis Reviews.

[31]  W. Jusko,et al.  Pharmacokinetic Principles of Drug Distribution in Saliva a , 1993, Annals of the New York Academy of Sciences.

[32]  A. Bradbury,et al.  Serum amylase isoenzymes in patients undergoing operation for ruptured and non-ruptured abdominal aortic aneurysm. , 1999, Journal of vascular surgery.

[33]  C. Streckfus,et al.  Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study , 2001, Clinical Oral Investigations.

[34]  John T McDevitt,et al.  Application of microchip assay system for the measurement of C-reactive protein in human saliva. , 2005, Lab on a chip.

[35]  L. Mitchell,et al.  New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva , 1997, Journal of clinical microbiology.

[36]  P. Schwartz,et al.  Saliva and Serum CA 125 Assays for Detecting Malignant Ovarian Tumors , 1990, Obstetrics and gynecology.

[37]  S. Miller.  Saliva testing--a nontraditional diagnostic tool. , 1994, Clinical laboratory science : journal of the American Society for Medical Technology.

[38]  C. Fanali,et al.  Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. , 2008, Journal of proteome research.

[39]  P. Cohen,et al.  On target with a new mechanism for the regulation of protein phosphorylation. , 1993, Trends in biochemical sciences.

[40]  David Elashoff,et al.  Salivary Proteomics for Oral Cancer Biomarker Discovery , 2008, Clinical Cancer Research.

[41]  H. Vogel,et al.  Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. , 2003, Cancer research.

[42]  P. Denny,et al.  Salivary mucin as related to oral Streptococcus mutans in elderly people. , 2000, Oral microbiology and immunology.

[43]  N. Gadel-Hak,et al.  Chronic liver disease and hepatitis C virus in Egyptian patients. , 1999 .

[44]  C. K. Svensson,et al.  Therapeutic Drug Monitoring in Saliva , 1992, Clinical pharmacokinetics.

[45]  F. Oppenheim,et al.  Saliva: a Dynamic Proteome , 2007, Journal of dental research.

[46]  David Elashoff,et al.  Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. , 2008, Clinical chemistry.

[47]  D. Sidransky,et al.  Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. , 1994, American journal of surgery.

[48]  E. Cone.  Saliva Testing for Drugs of Abuse , 1993, Annals of the New York Academy of Sciences.

[49]  David R Walt,et al.  Fiber-optic microsphere-based arrays for multiplexed biological warfare agent detection. , 2006, Analytical chemistry.

[50]  D. Wong,et al.  Human Saliva Proteome and Transcriptome , 2006, Journal of dental research.

[51]  David R. Walt,et al.  Fluorescence-Based Fibre Optic Arrays: A Universal Platform for Sensing , 2003 .

[52]  I. Mandel,et al.  A contemporary view of salivary research. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[53]  Jae Hoon Kim,et al.  Clinical significance of osteopontin expression in cervical cancer , 2008, Journal of Cancer Research and Clinical Oncology.

[54]  A. Carr,et al.  Systemic assessments utilizing saliva: part 1 general considerations and current assessments. , 2006, The International journal of prosthodontics.

[55]  Jacques Landry,et al.  Inhibition of Daxx-Mediated Apoptosis by Heat Shock Protein 27 , 2000, Molecular and Cellular Biology.

[56]  John R Yates,et al.  The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. , 2008, Journal of proteome research.

[57]  G. Bray,et al.  The prevention of type 2 diabetes , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[58]  S. Socransky,et al.  Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. , 2000, Journal of clinical periodontology.

[59]  Kristen L. Helton,et al.  Microfluidic Overview of Global Health Issues Microfluidic Diagnostic Technologies for Global Public Health , 2006 .

[60]  T. Monks,et al.  An integrated approach to identifying chemically induced posttranslational modifications using comparative MALDI-MS and targeted HPLC-ESI-MS/MS. , 2003, Chemical Research in Toxicology.

[61]  K. Rieger-Christ,et al.  Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection , 2003, Cancer.

[62]  G. E. Oxford,et al.  Concise Review: Saliva and Growth Factors: The Fountain of Youth Resides in Us All , 1995, Journal of dental research.

[63]  J. Berek,et al.  Ovarian cancer: epidemiology, biology, and prognostic factors. , 2000, Seminars in surgical oncology.

[64]  M. Navazesh,et al.  Methods for Collecting Saliva , 1993, Annals of the New York Academy of Sciences.

[65]  S. Humphrey,et al.  A review of saliva: normal composition, flow, and function. , 2001, The Journal of prosthetic dentistry.

[66]  D. Sidransky,et al.  Nucleic acid-based methods for the detection of cancer. , 1997, Science.

[67]  R. Mesía,et al.  Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women , 2004, Breast Cancer Research and Treatment.